-
1
المؤلفون: Elena Castro, Rebeca Lozano, Petros Grivas, Vadim Sokolov, Navonil De Sarkar, Bruce Montgomery, David Olmos, Celestia S. Higano, Alexandra O. Sokolova, Peter S. Nelson, Michael T. Schweizer, Catherine Handy Marshall, Emmanuel S. Antonarakis, Roman Gulati, Evan Y. Yu, Channing J. Paller, Todd Yezefski, Oliver Sartor, Heather H. Cheng, Elisa Ledet
المصدر: Prostate
مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Medication Therapy Management, Urology, Antineoplastic Agents, Ataxia Telangiectasia Mutated Proteins, Docetaxel, Poly(ADP-ribose) Polymerase Inhibitors, medicine.disease_cause, Article, Germline, Prostate cancer, chemistry.chemical_compound, Germline mutation, Internal medicine, Nitriles, Phenylthiohydantoin, medicine, Humans, Enzalutamide, Stage (cooking), Germ-Line Mutation, Neoplasm Staging, Retrospective Studies, BRCA2 Protein, Mutation, business.industry, Patient Selection, Middle Aged, Prostate-Specific Antigen, medicine.disease, Survival Analysis, Prostatic Neoplasms, Castration-Resistant, Exact test, chemistry, Benzamides, Androstenes, Neoplasm Grading, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da3cf10dae9e889d1cd31a6ea4440b25Test
https://doi.org/10.1002/pros.24236Test -
2
المؤلفون: Catherine Handy Marshall, Alan H. Bryce, Michael T. Schweizer, Mario A. Eisenberger, Heather H. Cheng, Andrea McNatty, Alexandra O. Sokolova, Emmanuel S. Antonarakis
المصدر: European Urology. 76:452-458
مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Urology, Genes, BRCA2, Genes, BRCA1, 030232 urology & nephrology, Antineoplastic Agents, Ataxia Telangiectasia Mutated Proteins, Piperazines, Germline, Olaparib, 03 medical and health sciences, Prostate cancer, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Humans, Gene, Aged, Retrospective Studies, business.industry, Hazard ratio, Middle Aged, medicine.disease, Confidence interval, Prostatic Neoplasms, Castration-Resistant, Exact test, Treatment Outcome, chemistry, 030220 oncology & carcinogenesis, Mutation, PARP inhibitor, Phthalazines, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34b26852fb468f11e42419e8cea2750aTest
https://doi.org/10.1016/j.eururo.2019.02.002Test -
3
المؤلفون: Fadi, Taza, Albert E, Holler, Wei, Fu, Hao, Wang, Nabil, Adra, Costantine, Albany, Ryan, Ashkar, Heather H, Cheng, Alexandra O, Sokolova, Neeraj, Agarwal, Adam, Kessel, Alan, Bryce, Nellie, Nafissi, Pedro, Barata, A Oliver, Sartor, Diogo, Bastos, Oren, Smaletz, Jacob E, Berchuck, Mary-Ellen, Taplin, Rahul, Aggarwal, Cora N, Sternberg, Panagiotis J, Vlachostergios, Ajjai S, Alva, Christopher, Su, Catherine H, Marshall, Emmanuel S, Antonarakis
المصدر: JCO Precis Oncol
مصطلحات موضوعية: BRCA2 Protein, Male, Prostatic Neoplasms, Castration-Resistant, BRCA1 Protein, Humans, Antineoplastic Agents, ORIGINAL REPORTS, Poly(ADP-ribose) Polymerase Inhibitors, Germ-Line Mutation, United States, Retrospective Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=pmid________::737f090decd8165f56d73bcb238f5a20Test
https://pubmed.ncbi.nlm.nih.gov/34778690Test